![A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis | Scientific Reports A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep20150/MediaObjects/41598_2016_Article_BFsrep20150_Fig1_HTML.jpg)
A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis | Scientific Reports
![Pharmaceutics | Free Full-Text | Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease Pharmaceutics | Free Full-Text | Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease](https://www.mdpi.com/pharmaceutics/pharmaceutics-15-00083/article_deploy/html/images/pharmaceutics-15-00083-g001.png)
Pharmaceutics | Free Full-Text | Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
![Neutrophil-mimicking nanoparticles intercept inflammation signals and suppress joint damages in experimental arthritis | Nature Portfolio Bioengineering Community Neutrophil-mimicking nanoparticles intercept inflammation signals and suppress joint damages in experimental arthritis | Nature Portfolio Bioengineering Community](https://bioengineeringcommunity.nature.com/cdn-cgi/image/metadata=copyright,fit=scale-down,format=auto,sharpen=1,quality=95/https://images.zapnito.com/uploads/7afa611a8f23bdd16c550b99255816a5/02434b3e-58f2-438a-9c1f-7baf92c40ee6.jpeg)
Neutrophil-mimicking nanoparticles intercept inflammation signals and suppress joint damages in experimental arthritis | Nature Portfolio Bioengineering Community
![Cells | Free Full-Text | Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins Cells | Free Full-Text | Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins](https://www.mdpi.com/cells/cells-10-01175/article_deploy/html/images/cells-10-01175-g001.png)
Cells | Free Full-Text | Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins
![Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis | Science Advances Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis | Science Advances](https://www.science.org/cms/10.1126/sciadv.abd6167/asset/1c675af8-f6e1-4d15-8448-078bc630e413/assets/graphic/abd6167-f1.jpeg)
Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis | Science Advances
![The promise and challenge of high-throughput sequencing of the antibody repertoire | Nature Biotechnology The promise and challenge of high-throughput sequencing of the antibody repertoire | Nature Biotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnbt.2782/MediaObjects/41587_2014_Article_BFnbt2782_Fig1_HTML.jpg)
The promise and challenge of high-throughput sequencing of the antibody repertoire | Nature Biotechnology
![Frontiers | A Structure-Based B-cell Epitope Prediction Model Through Combing Local and Global Features Frontiers | A Structure-Based B-cell Epitope Prediction Model Through Combing Local and Global Features](https://www.frontiersin.org/files/Articles/890943/fimmu-13-890943-HTML/image_m/fimmu-13-890943-g001.jpg)
Frontiers | A Structure-Based B-cell Epitope Prediction Model Through Combing Local and Global Features
![Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection | Science Immunology Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abd0205/asset/ad75cf75-9bd0-4e82-bb37-725c4f23f2d0/assets/images/large/sciimmunol.abd0205-f1.jpg)
Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection | Science Immunology
![IJMS | Free Full-Text | From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children IJMS | Free Full-Text | From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children](https://www.mdpi.com/ijms/ijms-24-03001/article_deploy/html/images/ijms-24-03001-g001.png)
IJMS | Free Full-Text | From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children
![Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning | Nature Reviews Immunology Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning | Nature Reviews Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnri3516/MediaObjects/41577_2013_Article_BFnri3516_Fig1_HTML.jpg)
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning | Nature Reviews Immunology
![B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41573-020-00092-2/MediaObjects/41573_2020_92_Fig1_HTML.png)
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
![Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies | Scientific Reports Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep34382/MediaObjects/41598_2016_Article_BFsrep34382_Fig1_HTML.jpg)
Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies | Scientific Reports
![Antibodies | Free Full-Text | Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules Antibodies | Free Full-Text | Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules](https://www.mdpi.com/antibodies/antibodies-11-00002/article_deploy/html/images/antibodies-11-00002-g001.png)
Antibodies | Free Full-Text | Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules
![An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model | Nature Communications An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-017-00576-7/MediaObjects/41467_2017_576_Fig1_HTML.jpg)
An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model | Nature Communications
![Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties | Molecular Pharmaceutics Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.1c00280/asset/images/medium/mp1c00280_0008.gif)
Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties | Molecular Pharmaceutics
![The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent | Scientific Reports The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-017-17948-0/MediaObjects/41598_2017_17948_Fig1_HTML.jpg)